Search images on Google Product Monograph
Active Ingredients:
- terbinafine hydrochloride, 1 %/%
DIN: 02031094
Dosage Form(s): CREAM
Route(s) of Administration: TOPICAL
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- D01 - ANTIFUNGALS FOR DERMATOLOGICAL USE (ATC, WHO, Wiki)
- D01A - ANTIFUNGALS FOR TOPICAL USE (ATC, WHO)
- D01AE - Other antifungals for topical use (ATC, WHO)
- D01AE15 - TERBINAFINE (WHO)
Reference brand drug: Lamisil
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 30G
Pharmaceutical standard: MFR
External Links for Lamisil:
Search on Google
- Lamisil side effects
- Lamisil dosage
- terbinafine hydrochloride side effects
- terbinafine hydrochloride dosage
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find lamisil photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.